April 22, 2025 2:25 PM

Latest:

Nike Call Frenzy Fuels Speculation For Vietnam Tariff Deal
$4000 Gold, And We’re Just Getting Started! | Peter Grandich
US to Restart Student Loan Collections in May
US Readies Up To 3,521% Tariff on Southeast Asian Solar Panels
Canada 2040: 9 In 10 Stay Trapped In The Class They’re Born Into

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Home
Latest
- Automotive
- Cannabis
- Commentary
- Full Analysis
- Gold
- Industrials
- Macro
- Oil
- Resources
- Technology
Resources
Energy
Technology
Coverage Companies
Verses AI
About
Contact Us

Ventripoint Diagnostics

Latest News Technology

Ventripoint Diagnostics Installs Whole Heart Analysis Device At Leading European Hospital

September 28, 2020 9:09 AMSeptember 28, 2020 11:11 AM Jay Lutz 0 Comments Ventripoint Diagnostics

Ventripoint Diagnostics (TSXV: VPT) this morning announced that its latest version of its whole heart analysis system, referred to as

Read more

Next →

Latest

Nike Call Frenzy Fuels Speculation For Vietnam Tariff Deal
$4000 Gold, And We’re Just Getting Started! | Peter Grandich
US to Restart Student Loan Collections in May
US Readies Up To 3,521% Tariff on Southeast Asian Solar Panels
Canada 2040: 9 In 10 Stay Trapped In The Class They’re Born Into
As Immigrant Workforce Shrinks, Florida Eyes Child Labor
Ford Says He Doesn’t Want Poilievre’s Job
Orogen Royalties To Be Acquired For $2.00 Per Share By Triple Flag Precious Metals

Video

Latest Macro Video Series

$4000 Gold, And We’re Just Getting Started! | Peter Grandich

April 22, 2025 1:38 PM JP Alegre 0

In this interview, Peter Grandich provides an analysis of the current global economic landscape, exploring the impact of Trump’s tariffs

Trending

Big Promises, Bigger Deficits: Inside the Liberal Party’s Costed Platform
Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million
Can Alberta Succeed Where Decades of Canadian High-Speed Rail Plans Have Failed?
Kinross Gold: Fire Shuts Down Their Largest Operation
Tariffied! Cleveland-Cliffs Not Immune To Market Meltdown

News

Biotech Latest News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Stocktwits Partners with Beehiiv to Launch Newsletter Platform for Finance Writers

April 16, 2025 2:54 PM JP Alegre 0

Latest News Resources

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

Home
About
Research
Discover
Contact Us
Disclaimer

Categories

Automotive
Biotech
Bonds
Cannabis
Commentary
Crypto
Education
Energy
Entertainment
Esports
ETFs
Food
Full Analysis
Healthcare
Industrials
Latest
Lithium
Macro
Market Movers
Mental Hurdles
News
Oil
Politics
Psychedelics
Real Estate
Resources
Retail
SPACs
Technology
Video Series

Copyright © 2025 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.